Early Relapse of Follicular Lymphoma after Rituximab-Based Biologic Doublet Upfront Therapy Is Associated with Increased Risk of Death: A Combined Analysis from CALGB Studies 50402, 50701 and 50803 (Alliance)
Year: 2016
Type: article
Source: Blood
Institutions: Dartmouth–Hitchcock Medical Center, Dartmouth Cancer Center, Duke University, Georgetown University, Georgetown University Medical Center, Georgetown Lombardi Comprehensive Cancer Center, Roswell Park Comprehensive Cancer Center, University of Vermont Medical Center, Weill Cornell Medicine, Cleveland Clinic, Memorial Sloan Kettering Cancer Center, Loyola University Medical Center, Washington University in St. Louis, Alvin J. Siteman Cancer Center, Cornell University, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2595033560